BioAtla (NASDAQ:BCAB – Free Report) had its price target cut by JMP Securities from $12.00 to $5.00 in a report issued on Thursday, Benzinga reports. They currently have a market outperform rating on the stock. Separately, HC Wainwright restated a buy rating and issued a $7.00 price target on shares of BioAtla in a research […]